Project Name: Collaborative Working- Novartis Re-imagining Care Pathways Collaborative Working Project for Norfolk and Norwich University Hospitals NHS Foundation Trust Heart Failure Service

Project Summary:

The Reimagining Care Pathways CWP is a service offered by Novartis, which comprises a series of workshops, with the aim of providing pathway mapping support to the CW Partner (healthcare and service teams) to:

  1. Improve efficiency and service effectiveness for the benefit of patient care.
  2. Address the local challenges they face in the delivery of patient care. 
     

The programme facilitates area teams (Trust or ICS) to identify areas for efficiency within their service for prioritisation. The programme will be carried out in a number of different institutions. The service is facilitated by the Novartis Solutions Implementation Manager (SIM) Team.

Planned Milestones:

 Milestone DescriptionMilestone Delivery DateMilestone Evidence
1SIM & CW Partner’s key stakeholders:  
Both parties agree the scope of the NRCP 
CWP and arrange the dates for the
stakeholder’s interviews.  
Execution of collaborative working agreement 
(CWA) date +4 weeks 
SIM: Meeting minutes 
2

SIM & CW Partner: 
Mapping the Pathway – 1:1 interviews 
(as a guide, allow 1 hour for each interview 
and aim to have them all completed within
circa 4 weeks)

Execution of collaborative working agreement 
(CWA) date +8 weeks
SIM: Meeting minutes 
3SIM & CW Partner: 
Mapping the Pathway – Workshop
(as a guide, circa 2 weeks from the last
interview) 
Execution of collaborative working agreement 
(CWA) date +10 weeks 
SIM:  
Pathway Map 

 
4SIM & CW Partner: 
Feedback/Consultation with NHS 
post workshop (as a guide,
no later than +4 weeks from workshop) 
Execution of collaborative working agreement 
(CWA) date +14 weeks 
SIM:  
Final Pathway Map Report detailing any 
identified any unmet needs / efficiency 
constraints in their service.
SIM 
Meeting minutes 


Expected Benefits:

Anticipated benefits for patients: 

We anticipate that some of the benefits for patients could include;
Potentially fewer visits and shorter waiting times as a result of a more efficient clinical pathway
Faster and more equitable access to the complete range of NICE approved treatment options.

Anticipated benefits to the CW Partner:

Improved understanding of the current service pathway, and associated efficiencies and inefficiencies. Potential to lead to solutions which could allow the CW Partner’s organisation to enhance both patient experience and outcomes. 

Anticipated benefits to Novartis:

Understanding of possible opportunities to partner with the CW Partner to enhance patient outcomes and experience. Better understanding of patients,’ carers and customers’ needs, which may inform future service offerings, and synergies between needs of the customer and value of Novartis offerings.  

Start Date & Duration: 9th May 2024, 14 weeks

UK2401197658

Project Name: Collaborative Working- Novartis Re-imagining Care Pathways Collaborative Working Project for Norfolk and Norwich University Hospitals NHS Foundation Trust Heart Failure Service 

Partner Organisation(s): Norfolk and Norwich University Hospitals NHS Foundation Trust (the “CW Partner”)

Completion Date: September 2024

Outcome Summary:

The key priorities for this project were to identify areas for improvement with the service the Norfolk and Norwich University Hospital offer to patients with the Heart Failure Service to improve overall efficiency and diagnose patients quicker and get the right treatment safely. 

Key Project Outcomes Data:

A report and patient pathway map were developed as part of the Collaborative Working Project, which demonstrated the following: 

  1. Improved understanding of the current service pathway, leading to potential solutions to enable positive change to the service. 
  2. Better understanding of patient's needs, which may inform future service offerings.
  3. Greater understanding of internal processes and technology could potentially be improved to help achieve a more efficient service delivery for both patients and staff. 

Outcomes:

The key areas identified for potential considerations are lack of clinic space, gap in administrative support, education of related services, upskilling of current staff and delays in access to echocardiogram. 

Conclusion:

This project provided a real-time snapshot of the Heart Failure service at the Norfolk and Norwich University Hospital. By mapping this pathway, we identified current challenges resulting in efficiencies in the pathway and provided potential quick win recommendations and long-term considerations which could help to alleviate them. 

FA-11373153 | March 2025